{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:09:44Z","timestamp":1792123784584,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"crossref","award":["S2020-JC-YB-0959"],"award-info":[{"award-number":["S2020-JC-YB-0959"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the fact that the majority of gallstones formed in the gallbladder are mainly composed of cholesterol, as they are formed from cholesterol-supersaturated bile, and hypercholesterolemia is a common metabolic disorder, which is closely related to cardiac, hepatic, renal and other oxidative damage inflammation and necrosis, there is still no consensus regarding the contribution of blood serum lipids in the pathogenesis of gallbladder stone disease (GSD). This study aimed to investigate the relationship between hypercholesterolemia and the risk of new-onset asymptomatic GSD, and to determine the prevalence of factors associated with new-onset asymptomatic GSD in patients with hypercholesterolemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, 927 Chinese patients with new-onset asymptomatic gallstone disease and 845 healthy controls were enrolled starting from August 2012. Patients were matched for age, gender, race, occupation, systolic blood pressure, diastolic blood pressure, and fasting blood glucose levels (FBG). Body mass index (BMI), nonalcoholic fatty liver disease (NAFLD) and serum lipids indexes were compared and the relationships between BMI, blood lipid and gallbladder stone hazards were examined by logistic multivariate regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The result showed a significantly higher morbidity with GSD in hypercholesterolemia than non-hypercholesterolemia patients (\u03a7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200917.211,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Of hypercholesterolemia patients, low density lipoprotein (OR\u2009=\u20091.493,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.029) and NAFLD (OR\u2009=\u20092.723,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.022) were significant risk factors for GSD, while being male (OR\u2009=\u20090.244,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.033), weight (OR\u2009=\u20090.961,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.022), high density lipoprotein (OR\u2009=\u20090.305,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and FBG (OR\u2009=\u20090.687,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.034) were significantly negatively correlated with GSD in univariate analysis. Multivariate logistic regression indicated weakly positive correlations with NAFLD (OR\u2009=\u20093.284,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.054), and significant negative correlations with weight (OR\u2009=\u20090.930,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.018), HDL-c (OR\u2009=\u20090.144,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and GSD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hypercholesterolemia acts as an independent risk factor for new-onset asymptomatic GSD, while obesity and NAFLD are synergistic factors. Interestingly, it is first reported that elevated weight was inversely associated with GSD in patients with hypercholesterolemia. The results of this study suggest that effective control of hyperlipidemia is of greater significance than weight loss, which might make the situation worse, in the prevention of GSD in obese patients with hyperlipidemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-020-01402-8","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T10:02:54Z","timestamp":1603447374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5322-5180","authenticated-orcid":false,"given":"Binwu","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"1402_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","volume":"20","author":"EA Shaffer","year":"2006","unstructured":"Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20:981\u201396.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1402_CR2","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1053\/j.gastro.2004.01.025","volume":"126","author":"MW Russo","year":"2004","unstructured":"Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, et al. Digestive and liver diseases statistics, 2004. Gastroenterology. 2004;126:1448\u201353.","journal-title":"Gastroenterology."},{"key":"1402_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-230X-14-83","volume":"14","author":"JY Chen","year":"2014","unstructured":"Chen JY, Hsu CT, Liu JH, Tung TH. Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan. BMC Gastroenterol. 2014;14:83.","journal-title":"BMC Gastroenterol"},{"key":"1402_CR4","doi-asserted-by":"publisher","first-page":"e6477","DOI":"10.1097\/MD.0000000000006477","volume":"96","author":"SB Kim","year":"2017","unstructured":"Kim SB, Kim KH, Kim TN, Heo J, Jung MK, Cho CM, et al. Sex differences in prevalence and risk factors of asymptomatic cholelithiasis in Korean health screening examinee: A retrospective analysis of a multicenter study. Medicine (Baltimore). 2017;96:e6477.","journal-title":"Medicine (Baltimore)"},{"key":"1402_CR5","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.3748\/wjg.v18.i31.4215","volume":"18","author":"LY Chen","year":"2012","unstructured":"Chen LY, Qiao QH, Zhang SC, Chen YH, Chao GQ, Fang LZ. Metabolic syndrome and gallstone disease. World J Gastroenterol. 2012;18:4215\u201320.","journal-title":"World J Gastroenterol"},{"key":"1402_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/SGA.0000000000000235","volume":"39","author":"M Pak","year":"2016","unstructured":"Pak M, Lindseth G. Risk factors for Cholelithiasis. Gastroenterol Nurs. 2016;39:297\u2013309.","journal-title":"Gastroenterol Nurs"},{"key":"1402_CR7","doi-asserted-by":"publisher","unstructured":"Di Ciaula A, Garruti G, Fr\u00fchbeck G, De Angelis M, de Bari O, Wang DQ, Lammert F, Portincasa P. The Role of Diet in the Pathogenesis of Cholesterol Gallstones. Curr Med Chem. 2019;26(19):3620\u201338. https:\/\/doi.org\/10.2174\/0929867324666170530080636.","DOI":"10.2174\/0929867324666170530080636"},{"key":"1402_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/07315724.2004.10719360","volume":"23","author":"A Cuevas","year":"2004","unstructured":"Cuevas A, Miquel JF, Reyes MS, Zanlungo S, Nervi F. Diet as a risk factor for cholesterol gallstone disease. J Am Coll Nutr. 2004;23:187\u201396.","journal-title":"J Am Coll Nutr"},{"key":"1402_CR9","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s12272-009-1809-6","volume":"32","author":"ES Hwang","year":"2009","unstructured":"Hwang ES. Cholesterol gallstone formation in hypercholesterolemia. Arch Pharm Res. 2009;32:1177\u20138.","journal-title":"Arch Pharm Res"},{"key":"1402_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4082\/kjfm.2016.37.4.205","volume":"37","author":"P Portincasa","year":"2016","unstructured":"Portincasa P, Di Ciaula A, Grattagliano I. Preventing a mass disease: the case of gallstones disease: role and competence for family physicians. Korean J Fam Med. 2016;37:205\u201313.","journal-title":"Korean J Fam Med"},{"key":"1402_CR11","first-page":"529","volume":"261","author":"HU Marschall","year":"2007","unstructured":"Marschall HU, Einarsson C. Gallstone disease. Korean J Fam Med. 2007;261:529\u201342.","journal-title":"Korean J Fam Med"},{"key":"1402_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-230X-6-36","volume":"6","author":"C Schafmayer","year":"2006","unstructured":"Schafmayer C, Hartleb J, Tepel J, Albers S, Freitag S, Volzke H, et al. Predictors of gallstone composition in 1025 symptomatic gallstones from northern Germany. BMC Gastroenterol. 2006;6:36.","journal-title":"BMC Gastroenterol"},{"key":"1402_CR13","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1001\/jama.2009.1601","volume":"302","author":"M Bodmer","year":"2009","unstructured":"Bodmer M, Brauchli YB, Krahenbuhl S, Jick SS, Meier CR. Statin use and risk of gallstone disease followed by cholecystectomy. Jama. 2009;302:2001\u20137.","journal-title":"Jama."},{"key":"1402_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/13510002.2020.1763714","volume":"25","author":"AMS AlSaad","year":"2020","unstructured":"AlSaad AMS, Alasmari F, Abuohashish HM, Mohany M, Ahmed MM, Al-Rejaie SS. Renin angiotensin system blockage by losartan neutralize hypercholesterolemia-induced inflammatory and oxidative injuries. Redox Rep. 2020;25:51\u20138.","journal-title":"Redox Rep"},{"key":"1402_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ctim.2018.07.001","volume":"40","author":"M Akbari-Fakhrabadi","year":"2018","unstructured":"Akbari-Fakhrabadi M, Heshmati J, Sepidarkish M, Shidfar F. Effect of sumac (Rhus Coriaria) on blood lipids: a systematic review and meta-analysis. Complement Ther Med. 2018;40:8\u201312.","journal-title":"Complement Ther Med"},{"key":"1402_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/0300060514561134","volume":"43","author":"S Sarac","year":"2015","unstructured":"Sarac S, Atamer A, Atamer Y, Can AS, Bilici A, Tacyildiz I, et al. Leptin levels and lipoprotein profiles in patients with cholelithiasis. J Int Med Res. 2015;43:385\u201392.","journal-title":"J Int Med Res"},{"key":"1402_CR17","doi-asserted-by":"crossref","unstructured":"Zhang J, Ma M, Nan X, Sheng B. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China. Braz J Med Biol Res. 2016;49(8).","DOI":"10.1590\/1414-431x20165272"},{"key":"1402_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1186\/s12889-018-6083-4","volume":"18","author":"H Chen","year":"2018","unstructured":"Chen H, Zhang R, Zheng Q, Yan X, Wu S, Chen Y. Impact of body mass index on long-term blood pressure variability: a cross-sectional study in a cohort of Chinese adults. BMC Public Health. 2018;18:1193.","journal-title":"BMC Public Health"},{"key":"1402_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12944-019-1148-7","volume":"18","author":"MY Lee","year":"2019","unstructured":"Lee MY, Nam GE, Han K, Kim DH, Kim YH, Cho KH, et al. Association between height and hypercholesterolemia in adults: a nationwide population-based study in Korea. Lipids Health Dis. 2019;18:198.","journal-title":"Lipids Health Dis"},{"key":"1402_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12944-018-0765-x","volume":"17","author":"B Wang","year":"2018","unstructured":"Wang B, Zhang Q, Lin L, Pan LL, He CY, Wan XX, et al. Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia. Lipids Health Dis. 2018;17:131.","journal-title":"Lipids Health Dis"},{"key":"1402_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/nu9030279","volume":"9","author":"PK Song","year":"2017","unstructured":"Song PK, Li H, Man QQ, Jia SS, Li LX, Zhang J. Trends in determinants of hypercholesterolemia among Chinese adults between 2002 and 2012: results from theNational nutrition survey. Nutrients. 2017;9:279.","journal-title":"Nutrients."},{"key":"1402_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/1751-2980.12685","volume":"20","author":"JG Fan","year":"2019","unstructured":"Fan JG, Wei L, Zhuang H, National Workshop on Fatty L, Alcoholic Liver Disease CSoHCMA, Fatty Liver Disease Expert Committee CMDA. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). J Dig Dis. 2019;20:163\u201373.","journal-title":"J Dig Dis"},{"issue":"2","key":"1402_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14712\/18059694.2019.58","volume":"45","author":"N Kurtul","year":"2002","unstructured":"Kurtul N, Pence S, Kocoglu H, Aksoy H, Capan Y. Serum lipid and lipoproteins in gallstone patients. Acta Med (Hradec Kralove). 2002;45(2):79\u201381.","journal-title":"Acta Med (Hradec Kralove)"},{"key":"1402_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000084525","volume":"71","author":"H Volzke","year":"2005","unstructured":"Volzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion. 2005;71:97\u2013105.","journal-title":"Digestion."},{"key":"1402_CR25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1017\/S000711451900028X","volume":"121","author":"HY Hsu","year":"2019","unstructured":"Hsu HY, Huang CY, Hwang LC. Sex difference of the predictive value of BMI, waist circumference and percentage body fat mass for gallstone disease. Br J Nutr. 2019;121:955\u201360.","journal-title":"Br J Nutr"},{"key":"1402_CR26","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/hep.26563","volume":"58","author":"S Stender","year":"2013","unstructured":"Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology. 2013;58:2133\u201341.","journal-title":"Hepatology."},{"key":"1402_CR27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1194\/jlr.M200102-JLR200","volume":"43","author":"G Bouchard","year":"2002","unstructured":"Bouchard G, Johnson D, Carver T, Paigen B, Carey MC. Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk. J Lipid Res. 2002;43:1105\u201313.","journal-title":"J Lipid Res"},{"key":"1402_CR28","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1210\/jc.2006-1318","volume":"92","author":"JW Jocken","year":"2007","unstructured":"Jocken JW, Langin D, Smit E, Saris WH, Valle C, Hul GB, et al. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocrinol Metab. 2007;92:2292\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1402_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/gut.52.1.109","volume":"52","author":"IJ Jonkers","year":"2003","unstructured":"Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F, et al. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut. 2003;52:109\u201315.","journal-title":"Gut."},{"key":"1402_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/MEG.0b013e3283477cc9","volume":"23","author":"PJ Banim","year":"2011","unstructured":"Banim PJ, Luben RN, Bulluck H, Sharp SJ, Wareham NJ, Khaw KT, et al. The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk). Eur J Gastroenterol Hepatol. 2011;23:733\u201340.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1402_CR31","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1665-2681(19)30765-3","volume":"14","author":"AR Radmard","year":"2015","unstructured":"Radmard AR, Merat S, Kooraki S, Ashraf M, Keshtkar A, Sharafkhah M, et al. Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences. Ann Hepatol. 2015;14:702\u20139.","journal-title":"Ann Hepatol"},{"key":"1402_CR32","first-page":"B5438","volume":"65","author":"DM Shabanzadeh","year":"2018","unstructured":"Shabanzadeh DM. New determinants for gallstone disease? Dan Med J. 2018;65:B5438.","journal-title":"Dan Med J"},{"key":"1402_CR33","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.gassur.2006.04.005","volume":"10","author":"A Nakeeb","year":"2006","unstructured":"Nakeeb A, Comuzzie AG, Al-Azzawi H, Sonnenberg GE, Kissebah AH, Pitt HA. Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg. 2006;10:940\u20138 discussion 8-9.","journal-title":"J Gastrointest Surg"},{"key":"1402_CR34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11605-003-0030-z","volume":"7","author":"KQ Tran","year":"2003","unstructured":"Tran KQ, Goldblatt MI, Swartz-Basile DA, Svatek C, Nakeeb A, Pitt HA. Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin-related murine obesity. J Gastrointest Surg. 2003;7:857\u201362 discussion 63.","journal-title":"J Gastrointest Surg"},{"key":"1402_CR35","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1007\/s10620-016-4125-2","volume":"61","author":"V Jaruvongvanich","year":"2016","unstructured":"Jaruvongvanich V, Sanguankeo A, Upala S. Significant association between gallstone disease and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Dig Dis Sci. 2016;61:2389\u201396.","journal-title":"Dig Dis Sci"},{"key":"1402_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1039\/c1fo10133a","volume":"2","author":"R Valenzuela","year":"2011","unstructured":"Valenzuela R, Videla LA. The importance of the long-chain polyunsaturated fatty acid n-6\/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food Funct. 2011;2:644\u20138.","journal-title":"Food Funct"},{"key":"1402_CR37","first-page":"191","volume":"47","author":"K Chien-Min","year":"2017","unstructured":"Chien-Min K, Cheng-Chuan L. Clinical criteria correlated with the incidence of patients with non-alcoholic fatty liver disease. Ann Clin Lab Sci. 2017;47:191\u2013200.","journal-title":"Ann Clin Lab Sci"},{"key":"1402_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.metabol.2013.10.001","volume":"63","author":"M Lappas","year":"2014","unstructured":"Lappas M. Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue. Metabolism. 2014;63:250\u201362.","journal-title":"Metabolism."},{"key":"1402_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.redox.2018.04.002","volume":"17","author":"F Alhasson","year":"2018","unstructured":"Alhasson F, Seth RK, Sarkar S, Kimono DA, Albadrani MS, Dattaroy D, et al. High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease. Redox Biol. 2018;17:1\u201315.","journal-title":"Redox Biol"},{"key":"1402_CR40","doi-asserted-by":"publisher","first-page":"25168","DOI":"10.3390\/ijms161025168","volume":"16","author":"MC Hernandez-Rodas","year":"2015","unstructured":"Hernandez-Rodas MC, Valenzuela R, Videla LA. Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease. Int J Mol Sci. 2015;16:25168\u201398.","journal-title":"Int J Mol Sci"},{"key":"1402_CR41","doi-asserted-by":"publisher","unstructured":"Meex RCR, Blaak EE. Mitochondrial Dysfunction is a Key Pathway that Links Saturated Fat Intake to the Development and Progression of NAFLD. Mol Nutr Food Res. 2020. p. e1900942. https:\/\/doi.org\/10.1002\/mnfr.201900942. Epub ahead of print.","DOI":"10.1002\/mnfr.201900942"},{"key":"1402_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tvjl.2013.10.019","volume":"199","author":"M Kutsunai","year":"2014","unstructured":"Kutsunai M, Kanemoto H, Fukushima K, Fujino Y, Ohno K, Tsujimoto H. The association between gall bladder mucoceles and hyperlipidaemia in dogs: a retrospective case control study. Vet J. 2014;199:76\u20139.","journal-title":"Vet J"},{"key":"1402_CR43","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nm1748","volume":"14","author":"V Teichgraber","year":"2008","unstructured":"Teichgraber V, Ulrich M, Endlich N, Riethmuller J, Wilker B, De Oliveira-Munding CC, et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med. 2008;14:382\u201391.","journal-title":"Nat Med"},{"key":"1402_CR44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.clnu.2019.05.004","volume":"39","author":"M Sepidarkish","year":"2020","unstructured":"Sepidarkish M, Akbari-Fakhrabadi M, Daneshzad E, Yavari M, Rezaeinejad M, Morvaridzadeh M, et al. Effect of omega-3 fatty acid plus vitamin E co-supplementation on oxidative stress parameters: a systematic review and meta-analysis. Clin Nutr. 2020;39:1019\u201325.","journal-title":"Clin Nutr"},{"key":"1402_CR45","first-page":"43","volume":"88","author":"RA Ivanchenkova","year":"2010","unstructured":"Ivanchenkova RA, Gatsenko VP, At'kova ER, Meshkov AN. Disorders of lipid metabolism in patients with cholelithiasis and gallbladder cholesterosis depending on apolipoprotein E genotype. Klin Med (Mosk). 2010;88:43\u20138.","journal-title":"Klin Med (Mosk)"},{"key":"1402_CR46","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/eurheartj\/ehv108","volume":"36","author":"BK Lauridsen","year":"2015","unstructured":"Lauridsen BK, Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A. Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease. Eur Heart J. 2015;36:1601\u20138.","journal-title":"Eur Heart J"},{"key":"1402_CR47","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/MEG.0b013e32833732c3","volume":"22","author":"PJ Banim","year":"2010","unstructured":"Banim PJ, Luben RN, Wareham NJ, Sharp SJ, Khaw KT, Hart AR. Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study. Eur J Gastroenterol Hepatol. 2010;22:983\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1402_CR48","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3736\/jcim20081011","volume":"6","author":"XL Zhang","year":"2008","unstructured":"Zhang XL, Liang XQ, Gu HG, Ma EW, Lin TB, Sun X, et al. Effects of Shengqing capsule on biochemical parameters in mice with cholesterol gallstone. Zhong Xi Yi Jie He Xue Bao. 2008;6:1045\u20138.","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"1402_CR49","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1194\/jlr.M700276-JLR200","volume":"49","author":"UJ Tietge","year":"2008","unstructured":"Tietge UJ, Nijstad N, Havinga R, Baller JF, van der Sluijs FH, Bloks VW, et al. Secretory phospholipase A2 increases SR-BI-mediated selective uptake from HDL but not biliary cholesterol secretion. J Lipid Res. 2008;49:563\u201371.","journal-title":"J Lipid Res"},{"key":"1402_CR50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12876-017-0674-x","volume":"17","author":"TCC Boerlage","year":"2017","unstructured":"Boerlage TCC, Haal S, Maurits de Brauw L, YIZ A, Bruin S, van de Laar A, et al. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial). BMC Gastroenterol. 2017;17:164.","journal-title":"BMC Gastroenterol"},{"key":"1402_CR51","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.020426","volume":"9","author":"FP Chilunga","year":"2019","unstructured":"Chilunga FP, Henneman P, Meeks KA, Beune E, Requena-Mendez A, Smeeth L, et al. Prevalence and determinants of type 2 diabetes among lean African migrants and non-migrants: the RODAM study. J Glob Health. 2019;9:020426.","journal-title":"J Glob Health"},{"key":"1402_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/ijms21010092","volume":"21","author":"CY Chiu","year":"2019","unstructured":"Chiu CY, Yen TE, Liu SH, Chiang MT. Comparative effects and mechanisms of chitosan and its derivatives on hypercholesterolemia in high-fat diet-fed rats. Int J Mol Sci. 2019;21:92.","journal-title":"Int J Mol Sci"},{"key":"1402_CR53","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3945\/ajcn.2009.27909","volume":"91","author":"TL Hernandez","year":"2010","unstructured":"Hernandez TL, Sutherland JP, Wolfe P, Allian-Sauer M, Capell WH, Talley ND, et al. Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet. Am J Clin Nutr. 2010;91:578\u201385.","journal-title":"Am J Clin Nutr"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01402-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-020-01402-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01402-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T19:43:18Z","timestamp":1634931798000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-020-01402-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1186\/s12944-020-01402-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-70058\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-70058\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-70058\/v2","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the First Affiliated Hospital of Xi\u2019an Jiaotong University. No.XJTU1AF2019LSK-017. All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}